These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 10194542

  • 1. Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin.
    Mathijssen RH, van Alphen RJ, de Jonge MJ, Verweij J, de Bruijn P, Loos WJ, Nooter K, Vernillet L, Stoter G, Sparreboom A.
    Anticancer Drugs; 1999 Jan; 10(1):9-16. PubMed ID: 10194542
    [Abstract] [Full Text] [Related]

  • 2. Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.
    Kudoh S, Fukuoka M, Masuda N, Yoshikawa A, Kusunoki Y, Matsui K, Negoro S, Takifuji N, Nakagawa K, Hirashima T.
    Jpn J Cancer Res; 1995 Apr; 86(4):406-13. PubMed ID: 7775263
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin.
    de Jonge MJ, Verweij J, de Bruijn P, Brouwer E, Mathijssen RH, van Alphen RJ, de Boer-Dennert MM, Vernillet L, Jacques C, Sparreboom A.
    J Clin Oncol; 2000 Jan; 18(1):195-203. PubMed ID: 10623710
    [Abstract] [Full Text] [Related]

  • 4. Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38.
    Chabot GG.
    Cancer Chemother Pharmacol; 1995 Jan; 36(6):463-72. PubMed ID: 7554037
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer.
    Fujitani K, Tsujinaka T, Hirao M.
    Oncology; 2003 Jan; 64(2):111-5. PubMed ID: 12566907
    [Abstract] [Full Text] [Related]

  • 6. Plasma pharmacokinetics of 7-ethyl-10-hydroxycamptothecin (SN-38) after intravenous administration of SN-38 and irinotecan (CPT-11) to rats.
    Kaneda N, Hosokawa Y, Yokokura T, Awazu S.
    Biol Pharm Bull; 1997 Sep; 20(9):992-6. PubMed ID: 9331983
    [Abstract] [Full Text] [Related]

  • 7. Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
    Saltz LB, Spriggs D, Schaaf LJ, Schwartz GK, Ilson D, Kemeny N, Kanowitz J, Steger C, Eng M, Albanese P, Semple D, Hanover CK, Elfring GL, Miller LL, Kelsen D.
    J Clin Oncol; 1998 Dec; 16(12):3858-65. PubMed ID: 9850031
    [Abstract] [Full Text] [Related]

  • 8. A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38.
    Sasaki Y, Mizuno S, Fujii H, Ohtsu T, Wakita H, Igarashi T, Itoh K, Sekine I, Miyata Y, Saijo N.
    Jpn J Cancer Res; 1995 Jan; 86(1):117-23. PubMed ID: 7737903
    [Abstract] [Full Text] [Related]

  • 9. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.
    Blaney SM, Takimoto C, Murry DJ, Kuttesch N, McCully C, Cole DE, Godwin K, Balis FM.
    Cancer Chemother Pharmacol; 1998 Jan; 41(6):464-8. PubMed ID: 9554590
    [Abstract] [Full Text] [Related]

  • 10. Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
    Allegrini G, Di Paolo A, Cerri E, Cupini S, Amatori F, Masi G, Danesi R, Marcucci L, Bocci G, Del Tacca M, Falcone A.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):585-93. PubMed ID: 16680463
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11.
    Sasaki Y, Yoshida Y, Sudoh K, Hakusui H, Fujii H, Ohtsu T, Wakita H, Igarashi T, Itoh K.
    Jpn J Cancer Res; 1995 Jan; 86(1):111-6. PubMed ID: 7737902
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.
    Chabot GG, Abigerges D, Catimel G, Culine S, de Forni M, Extra JM, Mahjoubi M, Hérait P, Armand JP, Bugat R.
    Ann Oncol; 1995 Feb; 6(2):141-51. PubMed ID: 7786822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity.
    Mick R, Gupta E, Vokes EE, Ratain MJ.
    J Clin Oncol; 1996 Jul; 14(7):2012-9. PubMed ID: 8683231
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical pharmacokinetics of irinotecan.
    Chabot GG.
    Clin Pharmacokinet; 1997 Oct; 33(4):245-59. PubMed ID: 9342501
    [Abstract] [Full Text] [Related]

  • 17. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D, Chabot GG, Armand JP, Hérait P, Gouyette A, Gandia D.
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [Abstract] [Full Text] [Related]

  • 18. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
    Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J, North American Brain Tumor Consortium study.
    Neuro Oncol; 2004 Jan; 6(1):44-54. PubMed ID: 14769140
    [Abstract] [Full Text] [Related]

  • 19. Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide.
    Sloan JA, Atherton P, Reid J, Pitot HC, Erlichman C, Schaaf L.
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):241-9. PubMed ID: 11592347
    [Abstract] [Full Text] [Related]

  • 20. Phase I and pharmacokinetic trial of weekly CPT-11.
    Rothenberg ML, Kuhn JG, Burris HA, Nelson J, Eckardt JR, Tristan-Morales M, Hilsenbeck SG, Weiss GR, Smith LS, Rodriguez GI.
    J Clin Oncol; 1993 Nov; 11(11):2194-204. PubMed ID: 8229134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.